Stay updated with breaking news from Codexis Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a report released on Tuesday morning. Several other analysts have also recently weighed in on CDXS. Stifel Nicolaus dropped their price objective on shares of Codexis from $9.00 to $5.00 and set a buy rating for the […]
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) insider Margaret Nell Fitzgerald purchased 11,834 shares of the stock in a transaction that occurred on Friday, September 8th. The stock was purchased at an average price of $1.70 per share, for a total transaction of $20,117.80. Following the acquisition, the insider now owns 81,420 shares in the […]
Benchmark restated their buy rating on shares of Codexis (NASDAQ:CDXS – Free Report) in a research note released on Friday, Benzinga reports. Benchmark currently has a $9.00 price objective on the biotechnology company’s stock. CDXS has been the subject of several other reports. HC Wainwright cut Codexis from a buy rating to a neutral rating […]
StockNews.com began coverage on shares of Codexis (NASDAQ:CDXS – Free Report) in a report released on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other brokerages also recently weighed in on CDXS. Stifel Nicolaus decreased their price objective on shares of Codexis from $9.00 to $5.00 and […]
Shares of Codexis, Inc. (NASDAQ:CDXS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]